Agilon Health AGL Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months)
Available-for-Sale Debt Securities - Unrealized Loss Position (<12 Months) at other companies
Other financials
Where this comes from
Reported directly by Agilon Health in its filing.
Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months.
The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Agilon Health's available-for-sale debt securities - unrealized loss position (<12 months).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Agilon Health's available-for-sale debt securities - unrealized loss position (<12 months)?
- Agilon Health (AGL) reported available-for-sale debt securities - unrealized loss position (<12 months) of $12.93M in Q4 2025.
- How has Agilon Health's available-for-sale debt securities - unrealized loss position (<12 months) changed year-over-year?
- Agilon Health's available-for-sale debt securities - unrealized loss position (<12 months) decreased by 48.9% year-over-year, from $25.3M to $12.93M.
- What is the long-term trend for Agilon Health's available-for-sale debt securities - unrealized loss position (<12 months)?
- Over 3 years (2022 to 2025), Agilon Health's available-for-sale debt securities - unrealized loss position (<12 months) has grown at a -68.3% compound annual growth rate (CAGR), from $407.4M to $12.93M.